Prøve GULL - Gratis
Buyouts, doubling overseas revenue on Lenskart agenda
Mint Mumbai
|September 08, 2023
Co to team up with 10 companies with majority or minority investments over 3 years: CEO
Eyewear unicorn Lenskart intends to double its international revenue and make several acquisitions, a top company executive said, after ending FY23 with a cash flow positive company, status and net profit.
The Gurugram-based backed by PremjiInvest, KKR, Temasek, Abu Dhabi Investment Authority (ADIA) and others, is planning to make smaller acquisitions through its Singapore-based subsidiary Neso Brands.
The omni-channel company is planning to team up with 10 companies with majority or minority investments over the next three years, co-founder and chief executive Peyush Bansal said in an interview.
"We have the distribution network that can help them grow. We will deploy funds depending on the size of the company and staff strength; all bets will be sub-$15 million (₹120 crore)," Bansal told VCCircle.
Denne historien er fra September 08, 2023-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Europe bets on $25 bn space budget amid defence hike
Europe’s equivalent of NASA is seeking €22 billion ($25.
1 min
November 27, 2025
Mint Mumbai
China’s ‘McNuggetization’: It’s beneficial for the environment
A wide-scope dietary shift in China is doing the planet a good turn
3 mins
November 27, 2025
Mint Mumbai
Flexi-cap funds in focus as smids falter
A silent pivot
3 mins
November 27, 2025
Mint Mumbai
Labour codes: Focus on empathy and not just efficiency
The consolidation of 29 archaic labour laws into four comprehensive new codes—on wages, social security, industrial relations and occupational safety—is among the most significant structural reforms undertaken by India in the post-liberalization era.
3 mins
November 27, 2025
Mint Mumbai
These firms will sell shovels during semaglutide gold rush
Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.
2 mins
November 27, 2025
Mint Mumbai
HC to hear Apple's plea on fine in Dec
Apple is challenging the new penalty math formula in India's competition law.
1 min
November 27, 2025
Mint Mumbai
Climate crisis: Innovation works, compression doesn't
After weeks of hot air, the UN’s CoP summit limped to an end in Brazil's Amazonian hub of Belém over the weekend, with a ‘deal’ that delivers nothing measurable for the climate, while wasting political capital and much effort on pledges.
3 mins
November 27, 2025
Mint Mumbai
MO Alternates launches its maiden private credit fund
The %3,000 crore fund has drawn capital from family offices, ultra-HNIs and institutions
3 mins
November 27, 2025
Mint Mumbai
Kharif grain production likely to rise to 173 mt
India's kharif foodgrain output is expected to rise to 173.
1 min
November 27, 2025
Mint Mumbai
IL&FS group repays ₹48,463 cr loan
Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.
1 min
November 27, 2025
Translate
Change font size

